Commonly referred to as antidepressants, selective serotonin reuptake inhibitors (SSRIs) are a classification of prescription medication designed to treat moderate to severe depression . They’ve grown in popularity thanks to their effectiveness, and their propensity to cause fewer side...
Read More... Oct 05, 2021Prescription & Medication Blog - Mental Health
Mental health affects millions and plays a key role in overall well-being. This category covers essential topics including common conditions like anxiety, depression, post-traumatic stress disorder (PTSD), and more, with clear information on symptoms, treatment options, and coping strategies. Whether you’re seeking help for yourself or supporting a loved one, our blogs provide practical advice on medication, lifestyle changes, and mental wellness techniques to promote a balanced life. Key topics include: RxSpark helps you access affordable prescription options, pharmacy discounts, health products, and related health services, supporting you in navigating new treatments and saving on medications.Trusted Resources and Advice for Managing Mental Health
We live in difficult times, and with much of the country locked down to prevent the spread of COVID-19, millions of us are adjusting to a life in quarantine, self-isolation, or abiding by social distancing guidelines. For most of us, the primary concern is the danger COVID-19 poses to our physical...
Read More... Apr 09, 2020Arriving home with a new baby is one of those special life events that new moms will always remember but it can also be an overwhelming and turbulent time. Consequently, it may be unsurprising that up to eight out of ten new mothers experience the “baby blues," a common phenomenon...
Read More... Apr 15, 2019Depression and anxiety is more commonly diagnosed in patients suffering atopic dermatitis than among the rest of the US population, a recent survey by the National Eczema Association (NEA) suggests. October is Eczema Awareness Month, during which the NEA is highlighting the impact of eczema on...
Read More... Oct 28, 2017